Adrienne C. Lahti - Publications

Affiliations: 
Psychiatry and Behavioral Neurobiology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
PET, fMRI, MR Spectroscopy, schizophrenia, bipolar disorder, psychotropic drugs, brain function

173 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Voineskos AN, Hawco C, Neufeld NH, Turner JA, Ameis SH, Anticevic A, Buchanan RW, Cadenhead K, Dazzan P, Dickie EW, Gallucci J, Lahti AC, Malhotra AK, Öngür D, Lencz T, et al. Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 23: 26-51. PMID 38214624 DOI: 10.1002/wps.21159  0.431
2022 Lahti AC. Discovery of early schizophrenia through neuroimaging. Psychiatry Research. 322: 114993. PMID 36773467 DOI: 10.1016/j.psychres.2022.114993  0.396
2022 Nelson EA, Kraguljac NV, Maximo JO, Armstrong W, Lahti AC. Dorsal striatial hypoconnectivity predicts antipsychotic medication treatment response in first-episode psychosis and unmedicated patients with schizophrenia. Brain and Behavior. e2625. PMID 36237115 DOI: 10.1002/brb3.2625  0.305
2022 King VL, Lahti AC, Maximo JO, Ver Hoef LW, John S, Kraguljac NV. Contrasting Frontoparietal Network Connectivity in Antipsychotic Medication-Naive First-Episode Psychosis Patients Who Do and Do Not Display Features of the Deficit Syndrome. Schizophrenia Bulletin. PMID 35869578 DOI: 10.1093/schbul/sbac081  0.3
2022 Samson GD, Lahti AC, Kraguljac NV. The neural substrates of neurological soft signs in schizophrenia: a systematic review. Schizophrenia (Heidelberg, Germany). 8: 42. PMID 35853869 DOI: 10.1038/s41537-022-00245-9  0.385
2021 Overbeek G, Gawne TJ, Reid MA, Kraguljac NV, Lahti AC. A multimodal neuroimaging study investigating resting-state connectivity, glutamate and GABA at 7 T in first-episode psychosis. Journal of Psychiatry & Neuroscience : Jpn. 46: E702-E710. PMID 34933941 DOI: 10.1503/jpn.210107  0.738
2021 Maximo JO, Briend F, Armstrong WP, Kraguljac NV, Lahti AC. Salience network glutamate and brain connectivity in medication-naïve first episode patients - A multimodal magnetic resonance spectroscopy and resting state functional connectivity MRI study. Neuroimage. Clinical. 32: 102845. PMID 34662778 DOI: 10.1016/j.nicl.2021.102845  0.41
2021 Kraguljac NV, Carle M, Frölich MA, Tran S, Yassa MA, White DM, Reddy A, Lahti AC. Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggest Dentate Gyrus Pathology Linked to NMDA Receptor Hypofunction. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 6: 1185-1192. PMID 34649019 DOI: 10.1016/j.bpsc.2021.09.008  0.386
2021 Lahti AC, Wang D, Pei H, Baker S, Narayan VA. Clinical Utility of Wearable Sensors and Patient-Reported Surveys in Patients With Schizophrenia: Noninterventional, Observational Study. Jmir Mental Health. 8: e26234. PMID 34383682 DOI: 10.2196/26234  0.314
2021 Kraguljac NV, Lahti AC. Neuroimaging as a Window Into the Pathophysiological Mechanisms of Schizophrenia. Frontiers in Psychiatry. 12: 613764. PMID 33776813 DOI: 10.3389/fpsyt.2021.613764  0.394
2020 Goodman AM, Allendorfer JB, Blum AS, Bolding MS, Correia S, Ver Hoef LW, Gaston TE, Grayson LE, Kraguljac NV, Lahti AC, Martin AN, Monroe WS, Philip NS, Tocco K, Vogel V, et al. White matter and neurite morphology differ in psychogenic nonepileptic seizures. Annals of Clinical and Translational Neurology. PMID 32991786 DOI: 10.1002/acn3.51198  0.61
2020 Gawne TJ, Overbeek GJ, Killen JF, Reid MA, Kraguljac NV, Denney TS, Ellis CA, Lahti AC. A multimodal magnetoencephalography 7 T fMRI and 7 T proton MR spectroscopy study in first episode psychosis. Npj Schizophrenia. 6: 23. PMID 32887887 DOI: 10.1038/s41537-020-00113-4  0.748
2020 Nelson EA, Kraguljac NV, Maximo JO, Briend F, Armstrong W, Ver Hoef LW, Johnson V, Lahti AC. Hippocampal Dysconnectivity and Altered Glutamatergic Modulation of the Default Mode Network: A Combined Resting-State Connectivity and Magnetic Resonance Spectroscopy Study in Schizophrenia. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 32684484 DOI: 10.1016/J.Bpsc.2020.04.014  0.471
2020 Kantrowitz JT, Grinband J, Goff DC, Lahti AC, Marder SR, Kegeles LS, Girgis RR, Sobeih T, Wall MM, Choo TH, Green MF, Yang YS, Lee J, Horga G, Krystal JH, et al. Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 32403118 DOI: 10.1038/S41386-020-0706-Z  0.345
2020 Kraguljac NV, Anthony T, Morgan CJ, Jindal RD, Burger MS, Lahti AC. White matter integrity, duration of untreated psychosis, and antipsychotic treatment response in medication-naïve first-episode psychosis patients. Molecular Psychiatry. PMID 32398721 DOI: 10.1038/S41380-020-0765-X  0.382
2020 Briend F, Nelson EA, Maximo O, Armstrong WP, Kraguljac NV, Lahti AC. Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis. Translational Psychiatry. 10: 137. PMID 32398671 DOI: 10.1038/S41398-020-0812-Z  0.419
2020 Briend F, Armstrong WP, Kraguljac NV, Keilhloz SD, Lahti AC. Aberrant static and dynamic functional patterns of frontoparietal control network in antipsychotic-naïve first-episode psychosis subjects. Human Brain Mapping. PMID 32372508 DOI: 10.1002/Hbm.24992  0.422
2020 Gurler D, White DM, Kraguljac NV, Ver Hoef L, Martin C, Tennant B, Lahti AC. Neural Signatures of Memory Encoding in Schizophrenia Are Modulated by Antipsychotic Treatment. Neuropsychobiology. 1-13. PMID 32316023 DOI: 10.1159/000506402  0.451
2020 Reddy-Thootkur M, Kraguljac NV, Lahti AC. The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders - A systematic review of magnetic resonance spectroscopy studies. Schizophrenia Research. PMID 32107102 DOI: 10.1016/J.Schres.2020.02.001  0.448
2020 Birur B, Kraguljac NV, VerHoef L, Morgan CJ, Jindal RD, Reid MA, Luker A, Lahti AC. Neurometabolic correlates of 6 and 16 weeks of treatment with risperidone in medication-naive first-episode psychosis patients. Translational Psychiatry. 10: 15. PMID 32066680 DOI: 10.1038/S41398-020-0700-6  0.699
2020 Nelson EA, Kraguljac NV, White DM, Jindal RD, Shin AL, Lahti AC. A Prospective Longitudinal Investigation of Cortical Thickness and Gyrification in Schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720904598. PMID 32022594 DOI: 10.1177/0706743720904598  0.482
2020 Roberts RC, McCollum LA, Schoonover KE, Mabry SJ, Roche JK, Lahti AC. Ultrastructural evidence for glutamatergic dysregulation in schizophrenia. Schizophrenia Research. PMID 32014360 DOI: 10.1016/J.Schres.2020.01.016  0.5
2020 Nelson E, Kraguljac N, Maximo J, Armstrong W, Lahti A. S151. Hippocampal Connectivity And Volume As Predictors Of Treatment Response – A Replication Study In Two Psychosis Cohorts Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa031.217  0.331
2020 Kraguljac N, Thomas A, Morgan C, Jindal R, Lahti A. T154. WHITE MATTER INTEGRITY, DURATION OF UNTREATED PSYCHOSIS, AND ANTIPSYCHOTIC TREATMENT RESPONSE IN MEDICATION-NAïVE FIRST EPISODE PSYCHOSIS PATIENTS Schizophrenia Bulletin. 46: S289-S289. DOI: 10.1093/Schbul/Sbaa029.714  0.373
2020 Maximo J, Briend F, Armstrong W, Kraguljac N, Lahti A. O2.2. EVALUATION OF THE RELATIONSHIP BETWEEN GLUTAMATE AND BRAIN CONNECTIVITY IN ANTIPSYCHOTIC-NAïVE FIRST EPISODE PATIENTS – A COMBINED MAGNETIC RESONANCE SPECTROSCOPY AND RESTING STATE FUNCTIONAL CONNECTIVITY MRI STUDY Schizophrenia Bulletin. 46. DOI: 10.1093/Schbul/Sbaa028.007  0.425
2020 Kraguljac N, Anthony T, Morgan C, Jindal R, Lahti A. White Matter Integrity, Duration of Untreated Psychosis, and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients Biological Psychiatry. 87: S240-S241. DOI: 10.1016/J.Biopsych.2020.02.1190  0.404
2019 Maximo JO, Nelson EA, Armstrong WP, Kraguljac NV, Lahti AC. Duration of Untreated Psychosis Correlates With Brain Connectivity and Morphology in Medication-Naïve Patients With First-Episode Psychosis. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 31902581 DOI: 10.1016/J.Bpsc.2019.10.014  0.435
2019 Lottman KK, Gawne TJ, Kraguljac NV, Killen JF, Reid MA, Lahti AC. Examining resting-state functional connectivity in first-episode schizophrenia with 7T fMRI and MEG. Neuroimage. Clinical. 24: 101959. PMID 31377556 DOI: 10.1016/J.Nicl.2019.101959  0.813
2019 Bryant JE, Frölich M, Tran S, Reid MA, Lahti AC, Kraguljac NV. Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism. Journal of Psychiatric Research. 117: 108-115. PMID 31376621 DOI: 10.1016/J.Jpsychires.2019.07.008  0.635
2019 Kraguljac NV, Anthony T, Monroe WS, Skidmore FM, Morgan CJ, White DM, Patel N, Lahti AC. A longitudinal neurite and free water imaging study in patients with a schizophrenia spectrum disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31153156 DOI: 10.1038/S41386-019-0427-3  0.489
2019 Kraguljac NV, Anthony T, Skidmore FM, Marstrander J, Morgan CJ, Reid MA, White DM, Jindal RD, Melas Skefos NH, Lahti AC. Micro- and Macrostructural White Matter Integrity in Never-Treated and Currently Unmedicated Patients With Schizophrenia and Effects of Short-Term Antipsychotic Treatment. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 30852126 DOI: 10.1016/J.Bpsc.2019.01.002  0.677
2019 Kraguljac NV, Morgan CJ, Reid MA, White DM, Jindal RD, Sivaraman S, Martinak BK, Lahti AC. A longitudinal magnetic resonance spectroscopy study investigating effects of risperidone in the anterior cingulate cortex and hippocampus in schizophrenia. Schizophrenia Research. PMID 30630705 DOI: 10.1016/J.Schres.2018.12.028  0.719
2019 Lahti A, Overbeek G, Gawne T, Kraguljac N, Reid M. 30.1 Relationship Between Cortical Excitation And Inhibition, Task-Induced Bold Response And Functional Connectivity: A Combined Mr Spectroscopy And Functional Mri Study At 7T In First Episode Psychosis Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz022.122  0.768
2019 Maximo J, Nelson E, Armstrong W, Edwards K, Kraguljac N, Lahti A. S86. DURATION OF UNTREATED PSYCHOSIS CORRELATES WITH BRAIN CONNECTIVITY IN ANTIPSYCHOTIC-NAïVE PATIENTS WITH FIRST EPISODE PSYCHOSIS Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz020.631  0.41
2019 Bryant E, Froelich M, Tran S, Reid M, Lahti A, Kraguljac N. T96. Ketamine Induced Changes In Regional Cerebral Blood Flow, Metabolic Connectivity, And Glutamate Metabolism Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz019.376  0.572
2019 Nelson E, White D, Kraguljac N, Reid M, Lahti A. T90. Neurobiological Signatures Of Antipsychotic Treatment Response – A Combined Magnetic Resonance Spectroscopy And Resting State Connectivity Study In Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz019.370  0.722
2019 Briend F, Nelson E, Armstrong W, Maximo J, Edwards K, Kraguljac N, Lahti A. T89. LONGITUDINAL EVALUATION OF GLUTAMATE AND N-ACETYL-ASPARTATE IN ANTIPSYCHOTIC-NAïVE FIRST EPISODE PSYCHOSIS SUBJECTS AND RELATIONSHIPS TO DURATION OF UNTREATED PSYCHOSIS AND RESPONSE TO ANTIPSYCHOTIC MEDICATION Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz019.369  0.419
2019 Gawne T, Lottman K, Reid M, Killen J, Kraguljac N, Lahti A. T80. Changes In The Overall Pattern Of Fmri And Meg Functional Connectivity In Patients With Schizophrenia Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz019.360  0.8
2019 Lahti A, Kraguljac N, Reid M, White D. 234. Hippocampal Glutamate and Resting State Functional Connectivity as Biomarkers of Treatment Response to Antipsychotic Medication Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.248  0.636
2019 Lieberman J, Goff D, Marder S, Lahti A, Javitt D, Kantrowitz J, Girgis R, Grinband J, Kegeles L, Wall M, Chou T. 117. Biomarker Assessment of Dose Dependent Target Engagement of mGluR-2,3 Partial Agonist for Schizophrenia Treatment Biological Psychiatry. 85: S49. DOI: 10.1016/J.Biopsych.2019.03.131  0.421
2018 Nelson EA, White DM, Kraguljac NV, Lahti AC. Gyrification Connectomes in Unmedicated Patients With Schizophrenia and Following a Short Course of Antipsychotic Drug Treatment. Frontiers in Psychiatry. 9: 699. PMID 30618873 DOI: 10.3389/Fpsyt.2018.00699  0.496
2018 Cadena EJ, White DM, Kraguljac NV, Reid MA, Maximo JO, Nelson EA, Gawronski BA, Lahti AC. A Longitudinal Multimodal Neuroimaging Study to Examine Relationships Between Resting State Glutamate and Task Related BOLD Response in Schizophrenia. Frontiers in Psychiatry. 9: 632. PMID 30555359 DOI: 10.3389/Fpsyt.2018.00632  0.73
2018 Overbeek G, Gawne TJ, Reid MA, Salibi N, Kraguljac NV, White DM, Lahti AC. Relationship Between Cortical Excitation and Inhibition and Task-Induced Activation and Deactivation: A Combined Magnetic Resonance Spectroscopy and Functional Magnetic Resonance Imaging Study at 7T in First-Episode Psychosis. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. PMID 30470582 DOI: 10.1016/J.Bpsc.2018.10.002  0.808
2018 Sivaraman S, Kraguljac NV, White DM, Morgan CJ, Gonzales SS, Lahti AC. Neurometabolic abnormalities in the associative striatum in antipsychotic-naïve first episode psychosis patients. Psychiatry Research. Neuroimaging. 281: 101-106. PMID 30286325 DOI: 10.1016/J.Pscychresns.2018.06.003  0.435
2018 Cadena EJ, White DM, Kraguljac NV, Reid MA, Jindal R, Pixley RM, Lahti AC. Cognitive control network dysconnectivity and response to antipsychotic treatment in schizophrenia. Schizophrenia Research. PMID 30098853 DOI: 10.1016/J.Schres.2018.07.045  0.724
2018 Cadena EJ, White DM, Kraguljac NV, Reid MA, Lahti AC. Evaluation of fronto-striatal networks during cognitive control in unmedicated patients with schizophrenia and the effect of antipsychotic medication. Npj Schizophrenia. 4: 8. PMID 29736018 DOI: 10.1038/s41537-018-0051-y  0.672
2018 Kraguljac NV, Carle M, Frölich MA, Tran S, Yassa MA, White DM, Reddy A, Lahti AC. Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggests Dentate Gyrus Pathology Linked to N-Methyl-D-Aspartate Receptor Hypofunction. Biological Psychiatry. Cognitive Neuroscience and Neuroimaging. 3: 231-238. PMID 29486864 DOI: 10.1016/J.Bpsc.2017.02.005  0.475
2018 Reid MA, Salibi N, White DM, Gawne TJ, Denney TS, Lahti AC. 7T Proton Magnetic Resonance Spectroscopy of the Anterior Cingulate Cortex in First-Episode Schizophrenia. Schizophrenia Bulletin. PMID 29385594 DOI: 10.1093/Schbul/Sbx190  0.826
2018 Lottman KK, White DM, Kraguljac NV, Reid MA, Calhoun VD, Catao F, Lahti AC. Four-way multimodal fusion of 7 T imaging data using an mCCA+jICA model in first-episode schizophrenia. Human Brain Mapping. PMID 29315951 DOI: 10.1002/Hbm.23906  0.704
2018 Kraguljac NV, Lahti AC. Paving the Way for Targeted Drug Development in Schizophrenia. Jama Psychiatry. 75: 19-20. PMID 29167884 DOI: 10.1001/Jamapsychiatry.2017.3501  0.413
2018 Gawne T, Overbeek G, Killen J, White D, Reid M, Salibi N, Denny T, Charles E, Lahti A. T19. Multimodal Imaging In First Episode Psychosis: Magnetoencephalography, 7T Fmri Stroop, And 7T Mrs Spectroscopy Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby016.295  0.732
2018 Kraguljac N, Thomas A, Skidmore F, White D, Lahti A. O6.6. Lack Of Antipsychotic Medication Effects On White Matter Microstructure In Schizophrenia. Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby015.227  0.406
2018 Lahti A, Reid M, White D, Kraguljac N. 25.2 Understanding White Matter Pathology In Schizophrenia Using Diffusion Tensor Imaging And Magnetic Resonance Spectroscopy. Schizophrenia Bulletin. 44. DOI: 10.1093/Schbul/Sby014.102  0.701
2018 Kraguljac N, Anthony T, Skidmore F, Monroe W, Marstrander J, White D, Lahti A. T245. Antipsychotic Medications do not Affect Abnormal Extracellular Free Water and Spatial Configuration of Neurites in Unmedicated Patients With Schizophrenia Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.582  0.46
2018 Birur B, Kraguljac N, White D, Lahti A. T244. Neurochemistry in the Medial Prefrontal Cortex in Medication-Naïve First Episode Psychosis and Response to Antipsychotic Treatment Biological Psychiatry. 83. DOI: 10.1016/J.Biopsych.2018.02.581  0.404
2017 Birur B, Kraguljac NV, Shelton RC, Lahti AC. Brain structure, function, and neurochemistry in schizophrenia and bipolar disorder-a systematic review of the magnetic resonance neuroimaging literature. Npj Schizophrenia. 3: 15. PMID 28560261 DOI: 10.1038/s41537-017-0013-9  0.391
2017 Harnett NG, Wood KH, Ference EW, Reid MA, Lahti AC, Knight AJ, Knight DC. Glutamate/glutamine concentrations in the dorsal anterior cingulate vary with Post-Traumatic Stress Disorder symptoms. Journal of Psychiatric Research. 91: 169-176. PMID 28478230 DOI: 10.1016/J.Jpsychires.2017.04.010  0.584
2017 Lottman KK, Kraguljac NV, White DM, Morgan CJ, Calhoun VD, Butt A, Lahti AC. Risperidone Effects on Brain Dynamic Connectivity-A Prospective Resting-State fMRI Study in Schizophrenia. Frontiers in Psychiatry. 8: 14. PMID 28220083 DOI: 10.3389/Fpsyt.2017.00014  0.405
2017 Kraguljac N, Reid M, White D, Lahti A. SA85. White Matter Connectivity as a Predictor of Response to Antipsychotic Treatment: A Diffusion Connectometry Study in Unmedicated Patients With Schizophrenia Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx023.083  0.669
2017 Gawne T, Overbeek G, Killen J, White D, Reid M, Salibi N, Denney T, Lahti A. SA71. A Multimodal Magnetoencephalography, 7T fMRI Stroop, and 7T MRS Spectroscopy Study in First-Episode Psychosis Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx023.070  0.738
2017 Overbeek G, Gawne T, White D, Reid M, Salibi N, Denney T, Lahti A. SA66. A Combined 7T Stroop fMRI and MRS Study in First-Episode Schizophrenia Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx023.065  0.809
2017 White D, Kraguljac N, Reid M, Lahti A. 47. Effect of Antipsychotic Medication on Hippocampal Function and Neurochemistry: A Longitudinal Study in Patients With Schizophrenia Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx021.066  0.681
2017 Lahti A, White D, Kraguljac N, Reid M. 4.4 Hippocampal Glutamate and Functional Connectivity as Biomarkers of Treatment Response to Antipsychotic Medication Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx021.015  0.636
2017 Lahti A. 4. Glutamatergic Findings in Schizophrenia: How to Make Sense of Them? Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx021.011  0.499
2017 Kraguljac N, Reid M, White D, Lahti A. 964. White Matter Integrity, Measured with Diffusion Connectometry, in Unmedicated Patients with Schizophrenia and Response to Antipsychotic Treatment Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.690  0.676
2017 Birur B, Kraguljac N, Shelton R, Lahti A. 631. Brain Structure, Function, and Neurochemistry across Schizophrenia and Bipolar Disorder – A Systematic Review of the Magnetic Resonance Neuroimaging Literature Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.501  0.469
2017 Lahti A, White D, Katiyar N, Pei H, Baker S. 325. Clinical Utility Study Towards the Use of Continuous Wearable Sensors and Patient Reported Surveys for Relapse Prediction in Patients at High Risk of Relapse in Schizophrenia Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.340  0.378
2016 Gawne TJ, Killen JF, Tracy JM, Lahti AC. The effect of saccadic eye movements on the sensor-level magnetoencephalogram. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 128: 397-407. PMID 28142055 DOI: 10.1016/J.Clinph.2016.12.013  0.592
2016 Kraguljac NV, Frölich MA, Tran S, White DM, Nichols N, Barton-McArdle A, Reid MA, Bolding MS, Lahti AC. Ketamine modulates hippocampal neurochemistry and functional connectivity: a combined magnetic resonance spectroscopy and resting-state fMRI study in healthy volunteers. Molecular Psychiatry. PMID 27480494 DOI: 10.1038/Mp.2016.122  0.809
2016 Hadley JA, Kraguljac NV, White DM, Ver Hoef L, Tabora J, Lahti AC. Change in brain network topology as a function of treatment response in schizophrenia: a longitudinal resting-state fMRI study using graph theory. Npj Schizophrenia. 2: 16014. PMID 27336056 DOI: 10.1038/npjschz.2016.14  0.707
2016 Kraguljac NV, White DM, Hadley N, Hadley JA, Ver Hoef L, Davis E, Lahti AC. Aberrant Hippocampal Connectivity in Unmedicated Patients With Schizophrenia and Effects of Antipsychotic Medication: A Longitudinal Resting State Functional MRI Study. Schizophrenia Bulletin. PMID 26873890 DOI: 10.1093/Schbul/Sbv228  0.744
2016 Kraguljac NV, White DM, Hadley JA, Visscher K, Knight D, Ver Hoef L, Falola B, Lahti AC. Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone. Neuroimage. Clinical. 10: 146-58. PMID 26793436 DOI: 10.1016/J.Nicl.2015.11.015  0.689
2016 Lahti AC. Making Progress Toward Individualized Medicine in the Treatment of Psychosis. The American Journal of Psychiatry. 173: 5-7. PMID 26725338 DOI: 10.1176/Appi.Ajp.2016.15101320  0.391
2015 White DM, Kraguljac NV, Reid MA, Lahti AC. Contribution of substantia nigra glutamate to prediction error signals in schizophrenia: a combined magnetic resonance spectroscopy/functional imaging study. Npj Schizophrenia. 1: 14001. PMID 26878032 DOI: 10.1038/npjschz.2014.1  0.655
2015 Reid MA, White DM, Kraguljac NV, Lahti AC. A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia. Schizophrenia Research. PMID 26718333 DOI: 10.1016/J.Schres.2015.12.003  0.709
2015 Libero LE, Reid MA, White DM, Salibi N, Lahti AC, Kana RK. Biochemistry of the cingulate cortex in autism: An MR spectroscopy study. Autism Research : Official Journal of the International Society For Autism Research. PMID 26526126 DOI: 10.1002/Aur.1562  0.624
2015 Roberts RC, Barksdale KA, Roche JK, Lahti AC. Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia. Schizophrenia Research. 168: 543-53. PMID 26210550 DOI: 10.1016/J.Schres.2015.07.016  0.349
2015 Robert SM, Buckingham SC, Campbell SL, Robel S, Holt KT, Ogunrinu-Babarinde T, Warren PP, White DM, Reid MA, Eschbacher JM, Berens ME, Lahti AC, Nabors LB, Sontheimer H. SLC7A11 expression is associated with seizures and predicts poor survival in patients with malignant glioma. Science Translational Medicine. 7: 289ra86. PMID 26019222 DOI: 10.1126/Scitranslmed.Aaa8103  0.569
2015 Libero LE, DeRamus TP, Lahti AC, Deshpande G, Kana RK. Multimodal neuroimaging based classification of autism spectrum disorder using anatomical, neurochemical, and white matter correlates. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 66: 46-59. PMID 25797658 DOI: 10.1016/J.Cortex.2015.02.008  0.378
2015 Hutcheson NL, Sreenivasan KR, Deshpande G, Reid MA, Hadley J, White DM, Ver Hoef L, Lahti AC. Effective connectivity during episodic memory retrieval in schizophrenia participants before and after antipsychotic medication. Human Brain Mapping. 36: 1442-57. PMID 25504918 DOI: 10.1002/Hbm.22714  0.818
2015 Roberts RC, Barksdale KA, Roche JK, Lahti AC. Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia Schizophrenia Research. DOI: 10.1016/j.schres.2015.07.016  0.304
2014 Bolding MS, Lahti AC, White D, Moore C, Gurler D, Gawne TJ, Gamlin PD. Vergence eye movements in patients with schizophrenia. Vision Research. 102: 64-70. PMID 25088242 DOI: 10.1016/J.Visres.2014.07.008  0.808
2014 Wheelock MD, Reid MA, To H, White DM, Cropsey KL, Lahti AC. Open label smoking cessation with varenicline is associated with decreased glutamate levels and functional changes in anterior cingulate cortex: preliminary findings. Frontiers in Pharmacology. 5: 158. PMID 25071576 DOI: 10.3389/Fphar.2014.00158  0.636
2014 Kraguljac NV, White DM, Hadley J, Reid MA, Lahti AC. Hippocampal-parietal dysconnectivity and glutamate abnormalities in unmedicated patients with schizophrenia. Hippocampus. 24: 1524-32. PMID 25045047 DOI: 10.1002/Hipo.22332  0.804
2014 Barksdale KA, Lahti AC, Roberts RC. Synaptic proteins in the postmortem anterior cingulate cortex in schizophrenia: relationship to treatment and treatment response. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2095-103. PMID 24603856 DOI: 10.1038/Npp.2014.57  0.432
2014 Weller RE, Avsar KB, Cox JE, Reid MA, White DM, Lahti AC. Delay discounting and task performance consistency in patients with schizophrenia. Psychiatry Research. 215: 286-93. PMID 24388727 DOI: 10.1016/J.Psychres.2013.11.013  0.795
2014 Hutcheson NL, Clark DG, Bolding MS, White DM, Lahti AC. Basal ganglia volume in unmedicated patients with schizophrenia is associated with treatment response to antipsychotic medication. Psychiatry Research. 221: 6-12. PMID 24210948 DOI: 10.1016/J.Pscychresns.2013.10.002  0.8
2014 Hadley JA, Nenert R, Kraguljac NV, Bolding MS, White DM, Skidmore FM, Visscher KM, Lahti AC. Ventral tegmental area/midbrain functional connectivity and response to antipsychotic medication in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 1020-30. PMID 24165885 DOI: 10.1038/Npp.2013.305  0.802
2014 White D, Kraguljac N, Reid M, Lahti A. fMRI measurements of prediction error and MRS measurements of midbrain glutamte in schizophrenia and healthy controls F1000research. 5. DOI: 10.7490/F1000Research.1096300.1  0.706
2013 Kraguljac NV, Srivastava A, Lahti AC. Memory deficits in schizophrenia: a selective review of functional magnetic resonance imaging (FMRI) studies. Behavioral Sciences (Basel, Switzerland). 3: 330-47. PMID 25379242 DOI: 10.3390/Bs3030330  0.433
2013 Avsar KB, Weller RE, Cox JE, Reid MA, White DM, Lahti AC. An fMRI investigation of delay discounting in patients with schizophrenia. Brain and Behavior. 3: 384-401. PMID 24381810 DOI: 10.1002/Brb3.135  0.801
2013 Kraguljac NV, White DM, Reid MA, Lahti AC. Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. Jama Psychiatry. 70: 1294-302. PMID 24108440 DOI: 10.1001/Jamapsychiatry.2013.2437  0.728
2013 Reid MA, Kraguljac NV, Avsar KB, White DM, den Hollander JA, Lahti AC. Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia. Schizophrenia Research. 147: 348-54. PMID 23706412 DOI: 10.1016/J.Schres.2013.04.036  0.831
2013 Bolding MS, Reid MA, Avsar KB, Roberts RC, Gamlin PD, Gawne TJ, White DM, den Hollander JA, Lahti AC. Magnetic transfer contrast accurately localizes substantia nigra confirmed by histology. Biological Psychiatry. 73: 289-94. PMID 22981657 DOI: 10.1016/J.Biopsych.2012.07.035  0.756
2013 Ambady P, Holdhoff M, Ferrigno C, Grossman S, Anderson MD, Liu D, Conrad C, Penas-Prado M, Gilbert MR, Yung AWK, Groot Jd, Aoki T, Nishikawa R, Sugiyama K, Nonoguchi N, ... ... Lahti A, et al. Neuro/Medical Oncology Neuro-Oncology. 15: 120-120. DOI: 10.1093/Neuonc/Not182  0.555
2012 Bolding MS, White DM, Hadley JA, Weiler M, Holcomb HH, Lahti AC. Antipsychotic Drugs Alter Functional Connectivity between the Medial Frontal Cortex, Hippocampus, and Nucleus Accumbens as Measured by H215O PET. Frontiers in Psychiatry. 3: 105. PMID 23230425 DOI: 10.3389/Fpsyt.2012.00105  0.791
2012 Bolding MS, Lahti AC, Gawne TJ, Hopkins KB, Gurler D, Gamlin PD. Ocular convergence deficits in schizophrenia. Frontiers in Psychiatry. 3: 86. PMID 23087652 DOI: 10.3389/Fpsyt.2012.00086  0.791
2012 Kraguljac NV, Reid M, White D, Jones R, den Hollander J, Lowman D, Lahti AC. Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis. Psychiatry Research. 203: 111-25. PMID 22981426 DOI: 10.1016/J.Pscychresns.2012.02.003  0.784
2012 Hutcheson NL, Reid MA, White DM, Kraguljac NV, Avsar KB, Bolding MS, Knowlton RC, den Hollander JA, Lahti AC. Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging. Schizophrenia Research. 140: 136-42. PMID 22831772 DOI: 10.1016/J.Schres.2012.06.039  0.79
2012 Kraguljac NV, Reid MA, White DM, den Hollander J, Lahti AC. Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 2635-42. PMID 22805603 DOI: 10.1038/Npp.2012.126  0.763
2012 Savage RM, Wiener HW, Nimgaonkar V, Devlin B, Calkins ME, Gur RE, O'Jile J, Bradford LD, Edwards N, Kwentus J, Allen T, McEvoy JP, Nasrallah H, Santos AB, Aduroja T, ... Lahti A, et al. Heritability of functioning in families with schizophrenia in relation to neurocognition. Schizophrenia Research. 139: 105-9. PMID 22627125 DOI: 10.1016/J.Schres.2012.04.015  0.433
2011 Avsar KB, Stoeckel LE, Bolding MS, White DM, Tagamets MA, Holcomb HH, Lahti AC. Aberrant visual circuitry associated with normal spatial match-to-sample accuracy in schizophrenia. Psychiatry Research. 193: 138-43. PMID 21782395 DOI: 10.1016/J.Pscychresns.2011.03.008  0.813
2011 Lahti AC, Reid MA. Is there evidence for neurotoxicity in the prodromal and early stages of schizophrenia? Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1779-80. PMID 21753798 DOI: 10.1038/Npp.2011.83  0.658
2011 Somerville SM, Lahti AC, Conley RR, Roberts RC. Mitochondria in the striatum of subjects with schizophrenia: relationship to treatment response. Synapse (New York, N.Y.). 65: 215-24. PMID 20665724 DOI: 10.1002/Syn.20838  0.385
2011 Avsar K, White D, Reid M, Stoeckel L, denHollander J, Lahti A. Combining 1 h MR spectroscopy and fmri during a prediction error task to evaluate the biochemical and functional properties of the sn/vta in individuals with schizophrenia and normal volunteers International Clinical Psychopharmacology. 26: e129. DOI: 10.1097/01.Yic.0000405852.79066.B4  0.813
2010 Reid MA, Stoeckel LE, White DM, Avsar KB, Bolding MS, Akella NS, Knowlton RC, den Hollander JA, Lahti AC. Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia. Biological Psychiatry. 68: 625-33. PMID 20570244 DOI: 10.1016/J.Biopsych.2010.04.013  0.82
2010 Hong LE, Summerfelt A, Buchanan RW, O'Donnell P, Thaker GK, Weiler MA, Lahti AC. Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 632-40. PMID 19890262 DOI: 10.1038/Npp.2009.168  0.418
2009 Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Cropsey KL. Modulation of limbic circuitry predicts treatment response to antipsychotic medication: a functional imaging study in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2675-90. PMID 19675535 DOI: 10.1038/Npp.2009.94  0.435
2009 Roberts RC, Roche JK, Conley RR, Lahti AC. Dopaminergic synapses in the caudate of subjects with schizophrenia: relationship to treatment response. Synapse (New York, N.Y.). 63: 520-30. PMID 19226604 DOI: 10.1002/Syn.20623  0.401
2006 Artaloytia JF, Arango C, Lahti A, Sanz J, Pascual A, Cubero P, Prieto D, Palomo T. Negative signs and symptoms secondary to antipsychotics: A double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers American Journal of Psychiatry. 163: 488-493. PMID 16513871 DOI: 10.1176/Appi.Ajp.163.3.488  0.349
2006 Lahti AC, Weiler MA, Holcomb HH, Tamminga CA, Carpenter WT, McMahon R. Correlations between rCBF and symptoms in two independent cohorts of drug-free patients with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 221-30. PMID 16123774 DOI: 10.1038/Sj.Npp.1300837  0.401
2005 Parwani A, Weiler MA, Blaxton TA, Warfel D, Hardin M, Frey K, Lahti AC. The effects of a subanesthetic dose of ketamine on verbal memory in normal volunteers. Psychopharmacology. 183: 265-74. PMID 16220331 DOI: 10.1007/S00213-005-0177-2  0.328
2005 Holcomb HH, Lahti AC, Medoff DR, Cullen T, Tamminga CA. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 2275-82. PMID 16034443 DOI: 10.1038/Sj.Npp.1300824  0.451
2005 Lahti AC, Weiler MA, Medoff DR, Tamminga CA, Holcomb HH. Functional effects of single dose first- and second-generation antipsychotic administration in subjects with schizophrenia. Psychiatry Research. 139: 19-30. PMID 15950442 DOI: 10.1016/J.Pscychresns.2005.02.006  0.393
2004 Holcomb HH, Parwani A, McMahon RP, Medoff DR, Frey K, Lahti AC, Tamminga CA. Parametric study of accuracy and response time in schizophrenic persons making visual or auditory discriminations. Psychiatry Research. 127: 207-16. PMID 15296820 DOI: 10.1016/J.Psychres.2004.04.003  0.45
2004 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M, Tamminga CA. Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 171-8. PMID 14520337 DOI: 10.1038/Sj.Npp.1300312  0.428
2003 Tamminga CA, Lahti AC, Medoff DR, Gao XM, Holcomb HH. Evaluating glutamatergic transmission in schizophrenia. Annals of the New York Academy of Sciences. 1003: 113-8. PMID 14684439 DOI: 10.1196/Annals.1300.062  0.483
2003 Lahti AC, Holcomb HH. Schizophrenia, VIII: pharmacologic models. The American Journal of Psychiatry. 160: 2091. PMID 14638574 DOI: 10.1176/Appi.Ajp.160.12.2091  0.473
2003 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Tamminga CA. Functional effects of antipsychotic drugs: comparing clozapine with haloperidol. Biological Psychiatry. 53: 601-8. PMID 12679238 DOI: 10.1016/S0006-3223(02)01602-5  0.4
2003 Tagamets M, Cortes C, Lahti A, Holcomb H, Tamminga C. An FMRI study of language organization in schizophrenia Schizophrenia Research. 60: 234-235. DOI: 10.1016/S0920-9964(03)81228-8  0.432
2003 Medoff D, Tamminga C, Lahti A, Holcomb H. Abnormal limbic system connectivity in schizophrenia Schizophrenia Research. 60: 228-229. DOI: 10.1016/S0920-9964(03)81211-2  0.508
2002 Avila MT, Weiler MA, Lahti AC, Tamminga CA, Thaker GK. Effects of ketamine on leading saccades during smooth-pursuit eye movements may implicate cerebellar dysfunction in schizophrenia. The American Journal of Psychiatry. 159: 1490-6. PMID 12202268 DOI: 10.1176/Appi.Ajp.159.9.1490  0.381
2001 Holcomb HH, Medoff DR, Lahti AC, Tamminga CA. Perceptual skill and brain physiology in subgroups of persons with schizophrenia. Dialogues in Clinical Neuroscience. 3: 294-5. PMID 22033645  0.34
2001 Medoff DR, Holcomb HH, Lahti AC, Tamminga CA. Probing the human hippocampus using rCBF: contrasts in schizophrenia. Hippocampus. 11: 543-50. PMID 11732707 DOI: 10.1002/Hipo.1070  0.512
2001 Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter WT. Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. The American Journal of Psychiatry. 158: 1797-808. PMID 11691685 DOI: 10.1176/Appi.Ajp.158.11.1797  0.468
2001 Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, Tamminga CA. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 455-67. PMID 11557159 DOI: 10.1016/S0893-133X(01)00243-3  0.402
2001 Holcomb HH, Lahti AC, Medoff DR, Weiler M, Tamminga CA. Sequential regional cerebral blood flow brain scans using PET with H2(15)O demonstrate ketamine actions in CNS dynamically. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 165-72. PMID 11425500 DOI: 10.1016/S0893-133X(01)00229-9  0.306
2001 Lahti AC, Warfel D, Michaelidis T, Weiler MA, Frey K, Tamminga CA. Long-term outcome of patients who receive ketamine during research. Biological Psychiatry. 49: 869-75. PMID 11343683 DOI: 10.1016/S0006-3223(00)01037-4  0.419
2000 Weiler MA, Thaker GK, Lahti AC, Tamminga CA. Ketamine effects on eye movements. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 645-53. PMID 11063920 DOI: 10.1016/S0893-133X(00)00156-1  0.42
2000 Holcomb HH, Lahti AC, Medoff DR, Weiler M, Dannals RF, Tamminga CA. Brain activation patterns in schizophrenic and comparison volunteers during a matched-performance auditory recognition task. The American Journal of Psychiatry. 157: 1634-45. PMID 11007718 DOI: 10.1176/Appi.Ajp.157.10.1634  0.432
2000 Carpenter WT, Gold JM, Lahti AC, Queern CA, Conley RR, Bartko JJ, Kovnick J, Appelbaum PS. Decisional capacity for informed consent in schizophrenia research. Archives of General Psychiatry. 57: 533-8. PMID 10839330 DOI: 10.1001/Archpsyc.57.6.533  0.412
2000 Tamminga CA, Vogel M, Gao X, Lahti AC, Holcomb HH. The limbic cortex in schizophrenia: focus on the anterior cingulate. Brain Research. Brain Research Reviews. 31: 364-70. PMID 10719164 DOI: 10.1016/S0165-0173(99)00053-3  0.48
2000 Lahti A, Weiler M, Parwani A, Holcomb H, Tamminga C. Blockade of ketamine-induced psychosis: A human model for a new spectrum of antipsychotic activity? Schizophrenia Research. 41: 236. DOI: 10.1016/S0920-9964(00)90893-4  0.313
2000 Holcomb H, Lahti A, Medoff D, Weiler M, Ma N, Tamminga C. Response time versus brain blood flow correlation patterns in a low error, sensory motor task: Normal volunteers vs patients with schizophrenia Schizophrenia Research. 41: 137. DOI: 10.1016/S0920-9964(00)90633-9  0.408
1999 Angrist BM, Baldessarini RJ, Bowers MB, Buchanan RW, Caroff SN, Casey DE, Chouinard G, Cole JO, Conley RR, Csernansky J, Daniel D, Davidson M, Davis J, Davis KL, DeLisi L, ... ... Lahti AC, et al. Treatment of schizophrenia 1999 Journal of Clinical Psychiatry. 60: 3-80. PMID 10380713  0.38
1998 Ross DE, Buchanan RW, Medoff D, Lahti AC, Thaker GK. Association between eye tracking disorder in schizophrenia and poor sensory integration. The American Journal of Psychiatry. 155: 1352-7. PMID 9766766 DOI: 10.1176/Ajp.155.10.1352  0.369
1998 Holcomb HH, Medoff DR, Caudill PJ, Zhao Z, Lahti AC, Dannals RF, Tamminga CA. Cerebral blood flow relationships associated with a difficult tone recognition task in trained normal volunteers. Cerebral Cortex (New York, N.Y. : 1991). 8: 534-42. PMID 9758216 DOI: 10.1093/Cercor/8.6.534  0.325
1998 Thaker GK, Ross DE, Cassady SL, Adami HM, LaPorte D, Medoff DR, Lahti A. Smooth pursuit eye movements to extraretinal motion signals: Deficits in relatives of patients with schizophrenia Archives of General Psychiatry. 55: 830-836. PMID 9736010 DOI: 10.1001/Archpsyc.55.9.830  0.375
1998 Ross DE, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Compton AD, Thaker GK. The relationship between smooth pursuit eye movements and tardive dyskinesia in schizophrenia. Schizophrenia Research. 31: 141-50. PMID 9689718 DOI: 10.1016/S0920-9964(98)00027-9  0.363
1998 Ross DE, Thaker GK, Buchanan RW, Lahti AC, Conley R, Medoff D. Specific measures account for most of the variance in qualitative ratings of smooth pursuit eye movements in schizophrenia. Archives of General Psychiatry. 55: 184-6. PMID 9477936 DOI: 10.1001/Archpsyc.55.2.184  0.389
1998 Lahti AC, Weiler MA, Corey PK, Lahti RA, Carlsson A, Tamminga CA. Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia. Biological Psychiatry. 43: 2-11. PMID 9442338 DOI: 10.1016/S0006-3223(97)00030-9  0.405
1998 Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Kile L, Michaelidis T, Fletcher S, Tamminga CA. Time course of rCBF changes after acute haloperidol in patients with schizophrenia Neuroimage. 7: S245. DOI: 10.1016/S1053-8119(18)31078-4  0.456
1998 Lahti A, Chen L, Warfel D, Corey P, Bartko J, Tamminga C. The factor structure for psychotic symptoms in patients with schizophrenia over three clinical states Schizophrenia Research. 29: 31-32. DOI: 10.1016/S0920-9964(97)88367-3  0.434
1997 Ross DE, Thaker GK, Buchanan RW, Kirkpatrick B, Lahti AC, Medoff D, Bartko JJ, Goodman J, Tien A. Eye tracking disorder in schizophrenia is characterized by specific ocular motor defects and is associated with the deficit syndrome. Biological Psychiatry. 42: 781-96. PMID 9347127 DOI: 10.1016/S0920-9964(97)82702-8  0.407
1997 Thaker GK, Ross D, Adami H, Buchanan R, Lahti A. Smooth pursuit eye movements (SPEM) to extraretinal motion signals in schizophrenia Schizophrenia Research. 24: 245. DOI: 10.1016/S0920-9964(97)82706-5  0.363
1997 Lahti AC, Lahti RA, Carlsson A, Tamminga CA. The treatment of schizophrenia with partial dopamine agonist: A promising strategy Schizophrenia Research. 24: 207. DOI: 10.1016/S0920-9964(97)82595-9  0.436
1997 Lahti A, Silber C, Mack R. The action of sertindole on negative symptoms in schizophrenia Schizophrenia Research. 24: 202. DOI: 10.1016/S0920-9964(97)82579-0  0.448
1997 Lahti AC, Holcomb HH, Carpenter WT, Zhao M, Buchanan RW, Tamminga CA. Blood flow activation differences during an auditory task in schizophrenic patients with and without primary negative symptoms Schizophrenia Research. 24: 167. DOI: 10.1016/S0920-9964(97)82480-2  0.302
1997 Holcomb HH, Lahti A, Medoff D, Zhao Z, Weiler M, Corey P, Warfel D, Tamminga CA. Ketamine induced cerebellarcingulate rCBF correlations and rCBF patterns in normal volunteers (NV) and schizophrenic patients (SZ) Schizophrenia Research. 24: 166. DOI: 10.1016/S0920-9964(97)82477-2  0.329
1997 Thoroughman KA, Weiler MA, Lahti AC, Tamminga CA, Holcomb HH. Implicit motor learning and memory in schizophrenia Schizophrenia Research. 24: 127. DOI: 10.1016/S0920-9964(97)82358-4  0.374
1997 LaPorte DJ, Corey PK, Lahti AC, Tamminga CA. Comparison of hippocampal test performance in schizophrenic inpatients stabilized with typical antipsychotic medication and medication free Schizophrenia Research. 24: 112. DOI: 10.1016/S0920-9964(97)82313-4  0.306
1996 Thaker GK, Ross DE, Buchanan RW, Moran MJ, Lahti A, Kim C, Medoff D. Does pursuit abnormality in schizophrenia represent a deficit in the predictive mechanism? Psychiatry Research. 59: 221-37. PMID 8930028 DOI: 10.1016/0165-1781(95)02759-9  0.309
1996 LaPorte DJ, Lahti AC, Koffel B, Tamminga CA. Absence of ketamine effects on memory and other cognitive functions in schizophrenia patients. Journal of Psychiatric Research. 30: 321-30. PMID 8923336 DOI: 10.1016/0022-3956(96)00018-0  0.391
1996 Tamminga CA, Lahti AC. The new generation of antipsychotic drugs. International Clinical Psychopharmacology. 11: 73-6. PMID 8803664 DOI: 10.1097/00004850-199605002-00012  0.36
1996 Ross DE, Thaker GK, Buchanan RW, Lahti AC, Medoff D, Bartko JJ, Moran M, Hartley J. Association of abnormal smooth pursuit eye movements with the deficit syndrome in schizophrenic patients. The American Journal of Psychiatry. 153: 1158-65. PMID 8780419  0.307
1996 Lahti A, Holcomb H, Carpenter W, Caudill P, Zhao M, Albert P, Medoff D, Tamminga C. rCBF pattern differences between medication-free schizophrenic patients with and without deficit symptoms Schizophrenia Research. 18: 195. DOI: 10.1016/0920-9964(96)85610-6  0.337
1996 Holcomb H, Lahti A, Caudill P, Zhao Z, Medoff D, Carpenter W, Albert P, Tamminga C. rCBF pattern contrasts between normal volunteers and medication-free schizophrenics derived from a difficult tone recognition task Schizophrenia Research. 18: 194. DOI: 10.1016/0920-9964(96)85607-6  0.309
1996 Lahti A, Weiler M, Corey P, Warfel D, Lahti R, Carlsson A, Tamminga C. Treatment of schizophrenia: New antidopaminergic strategies Biological Psychiatry. 39: 597. DOI: 10.1016/0006-3223(96)84276-4  0.46
1995 Tamminga CA, Holcomb HH, Gao XM, Lahti AC. Glutamate pharmacology and the treatment of schizophrenia: current status and future directions. International Clinical Psychopharmacology. 10: 29-37. PMID 8866763 DOI: 10.1097/00004850-199509000-00005  0.524
1995 Lahti AC, Koffel B, LaPorte D, Tamminga CA. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 13: 9-19. PMID 8526975 DOI: 10.1016/0893-133X(94)00131-I  0.419
1995 Lahti AC, Tamminga CA. Recent developments in the neuropharmacology of schizophrenia. American Journal of Health-System Pharmacy : Ajhp : Official Journal of the American Society of Health-System Pharmacists. 52: S5-8. PMID 7749964 DOI: 10.1093/Ajhp/52.3_Suppl_1.S5  0.466
1995 Lahti AC, Holcomb HH, Medoff DR, Tamminga CA. Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport. 6: 869-72. PMID 7612873 DOI: 10.1097/00001756-199504190-00011  0.371
1995 Lahti RA, Lahti AC, Tamminga CA, Ranhosky, Kleber HD, Wise RA, Sethy. D2-family receptors in schizophrenia: Distribution and implications for treatment Clinical Neuropharmacology. 18: S110-S120. DOI: 10.1097/00002826-199501001-00013  0.387
1995 Lahti AC, Holcomb HH, Zhao M, Medoff DR, Tamminga CA. The glutamatergic system and schizophrenia Schizophrenia Research. 15: 157-158. DOI: 10.1016/0920-9964(95)95488-U  0.496
1995 Lahti A, Albert P, Warfel D, Lahti R, Tamminga C. Novel antidopaminergic strategies for the treatment of schizophrenia Schizophrenia Research. 15: 157. DOI: 10.1016/0920-9964(95)95487-T  0.473
1995 Caudill PJ, Holcomb HH, Medoff D, Lahti A. Psychophysical differences in an auditory recognition task with schizophrenic patients and normal volunteers Schizophrenia Research. 15: 122-123. DOI: 10.1016/0920-9964(95)95377-L  0.308
1995 Lahti AC, Tamminga CA, Holcomb HH, Caudill PJ, Zhao M, Medoff DR, Carpenter WT. rCBF pattern differences between schizophrenic patients with and without enduring negative symptoms (deficit symptoms) Schizophrenia Research. 15: 89. DOI: 10.1016/0920-9964(95)95277-G  0.311
1994 Lahti A, Lahti R, Carlsson A, Tamminga C. The efficacy of the partial dopamine agonist (-)-3PPP in schizophrenia Biological Psychiatry. 35: 746. DOI: 10.1016/0006-3223(94)91131-2  0.436
1993 Thaker G, Adami H, Moran M, Lahti A, Cassady S. Psychiatric illnesses in families of subjects with schizophrenia-spectrum personality disorders: High morbidity risks for unspecified functional psychoses and schizophrenia American Journal of Psychiatry. 150: 66-71. PMID 8417582 DOI: 10.1176/Ajp.150.1.66  0.438
1993 Lahti A, Gao X, Cascella N, Mokriski B, LaPorte D, Lahti R, Tamminga C. Can NMDA antagonists help us understand the psychosis mechanism in schizophrenia? Schizophrenia Research. 9: 241-242. DOI: 10.1016/0920-9964(93)90541-P  0.454
1993 Lahti A, Cascella N, Conley R, Lahti R, Carlsson A, Tamminga C. Pharmacologic properties and antipsychotic effect of (-)-3PPP in schizophrenic patients Schizophrenia Research. 9: 241. DOI: 10.1016/0920-9964(93)90540-Y  0.371
1991 Thaker GK, Ellsberry R, Moran M, Lahti A. Tobacco smoking increases square-wave jerks during pursuit eye movements Biological Psychiatry. 29: 82-88. PMID 2001447 DOI: 10.1016/0006-3223(91)90212-5  0.317
1989 Thaker G, Kirkpatrick B, Buchanan RW, Ellsberry R, Lahti A, Tamminga C. Oculomotor abnormalities and their clinical correlates in schizophrenia Psychopharmacology Bulletin. 25: 491-497. PMID 2626522  0.306
Show low-probability matches.